David Dadiomov, PharmD, BCPP
Faculty Directory

David DadiomovPharmD, BCPP

David DadiomovPharmD, BCPP

Assistant Professor of Clinical Pharmacy | Director, PGY2 Psychiatric Pharmacy Program

Titus Family Department of Clinical Pharmacy

David Dadiomov, PharmD, BCPP, is an Assistant Professor of Clinical Pharmacy in the Titus Family Department of Clinical Pharmacy.

He received his PharmD from the University of Michigan College of Pharmacy. Dadiomov completed his PGY1 Pharmacy Residency at University of Michigan Health, and his PGY2 Psychiatric Pharmacy Residency at University of California- San Diego Health. He holds board certification in psychiatric pharmacy.

Dadiomov serves as the director of the PGY2 Psychiatric Pharmacy Residency Program. He maintains clinical practice in addiction medicine at Los Angeles General Medical Center. In this role he provides consultations in psychiatry and addiction as well as seeing patients in the Complex Care Clinic. Dadiomov has worked with the LA County Department of Health Services to establish novel clinical pharmacy services for patients experiencing homelessness, patients currently or recently released from incarceration, as well as those with severe mental illness and addiction disorders.

    Areas of Expertise

    • Substance Use Disorders
    • Addiction
    • Psychiatric Disorders
    • Clinical Pharmacy
    • Psychopharmacology
    • Psychoactive Substances
    • Homelessness
    • Correctional Healthcare
    • Education

      University of Michigan College of Pharmacy


      University of Michigan Health


      UC San Diego Health


    • Links
    • Selected Articles

      Safety of Repeated Administration of Parenteral Ketamine for Depression

      David Feifel, David Dadiomov, Kelly Lee

      Read More

      Laboratory Testing for Substance Use Disorders

      Absolute Addiction Psychiatry Review
      David Dadiomov

      Read More

      Therapeutic Drug Monitoring of Antipsychotics

      Current Psychiatry
      David Dadiomov

      Read More

      Dissociating the Clinical Role and Economic Value of Intranasal Esketamine

      Journal of Managed Care & Specialty Pharmacy
      David Dadiomov

      Read More

      The effects of ketamine on suicidality across various formulations and study settings

      Mental Health Clinician
      David Dadiomov and Kelly Lee

      Read More

      Using the LACE Score as a Predictor of Clinical Outcomes in Patients Referred for Inpatient Palliative Care Consultation: A Single-Center Experience

      American Journal of Hospice and Palliative Medicine
      David Dadiomov, Patricia Keefer, and Michael A. Smith

      Read More

      Lowering barriers to naloxone access through a student-led harm reduction program

      Journal of the American Pharmacists Association
      Brown M, Tran C, Dadiomov D

      Read More

      Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic

      Harm Reduction Journal
      Dadiomov D, Bolshakova M, Mikhaeilyan M, Trotzky-Sirr R

      Read More

      Changes in the availability of medications for opioid use disorder in prisons and jails in the United States during the COVID-19 pandemic

      Drug and Alcohol Dependence
      Dadiomov D, Trotzky-Sirr R, Shooshtari A, Qato D

      Read More

      Providing Low-barrier Addiction Treatment Via a Telemedicine Consultation Service During the COVID-19 Pandemic in Los Angeles, County: An Assessment 1 Year Later

      Journal of Addiction Medicine

      Read More

      Prevalence and distribution of high‐risk prescription opioid use in the United States, 2011–2016

      Pharmacoepidemiology and drug safety

      Read More

      Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic

      American Journal of Health-System Pharmacy

      Read More

      Inappropriate Quetiapine Use at a large academic medical center: frequency of misuse and associated costs of adverse effects

      Therapeutic Advances in Drug Safety
      Roth WR, Dadiomov D, Chu M

      Read More

      Adverse childhood experiences among California student pharmacists

      Mental Health Clinician

      Read More

    • Research Grants

      Overcoming Pharmacy-Level Barriers to MOUD Dispensing

      Foundation for Opioid Response Efforts,

      The team of investigators will create evidence-based practice guidelines and educational programming to encourage pharmacists to dispense buprenorphine, a medication used for the treatment of OUD.

      Read More

    • Selected Media Appearances

      Dadiomov Joins Faculty

      USC News | 06/10/2019

      David Dadiomov, PharmD, BCPP, has joined the faculty of the Titus Department of Clinical Pharmacy as clinical assistant professor of pharmacy practice.

      Read More

      MDMA Could Soon Receive FDA Approval

      The Messenger

      Read More

      After second high-profile crime linked to psychedelic mushrooms, experts talk about how they affect the brain

      NBC -King5 Seattle

      Read More

      'Very Aggressive Treatment' on the streets of Skid Row

      LA Times

      Read More